Local Application of lsogenic Adipose-Derived Stem Cells Restores Bone Healing Capacity in a Type 2 Diabetes Model

被引:33
作者
Wallner, Christoph [1 ]
Abraham, Stephanie [1 ]
Wagner, Johannes Maximilian [1 ]
Harati, Kamran [1 ]
Ismer, Britta [1 ]
Kessler, Lukas [1 ]
Zoellner, Hannah [1 ]
Lehnhardt, Marcus [1 ]
Behr, Bjoern [1 ]
机构
[1] Ruhr Univ Bochum, Univ Hosp Bergmannsheil, Dept Plast Surg, Bochum, Germany
关键词
Bone; Stem cells; Diabetes mellitus; Fractures; Osteogenesis; OSTEOBLAST GENE-EXPRESSION; OSTEOGENESIS; ANGIOGENESIS; MELLITUS; MATRIX;
D O I
10.5966/sctm.2015-0158
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Bone regeneration is typically a reliable process without scar formation. The endocrine disease type 2 diabetes prolongs and impairs this healing process. In a previous work, we showed that angiogenesis and osteogenesis essential steps of bone regeneration are deteriorated, accompanied by reduced proliferation in type 2 diabetic bone regeneration. The aim of the study was to improve these mechanisms by local application of adipose-derived stem cells (ASCs) and facilitate bone regeneration in impaired diabetic bone regeneration. The availability of ASCs in great numbers and the relative ease of harvest offers unique advantages over other mesenchymal stem cell entities. A previously described unicortical tibial defect model was utilized in diabetic mice (Lepr(db-/-)). Isogenic mouse adipose derived stem cells (mASCs)(db-/db-) were harvested, transfected with a green fluorescent protein vector, and isografted into tibial defects (150,000 living cells per defect). Alternatively, control groups were treated with Dulbecco's modified Eagle's medium or mASCs(WT). In addition, wild-type mice were identically treated. By means of immunohistochemistry, proteins specific for angiogenesis, cell proliferation, cell differentiation, and bone formation were analyzed at early (3 days) and late (7 days) stages of bone regeneration. Additionally, histomorphometry was performed to examine bone formation rate and remodeling. Histomorphometry revealed significantly increased bone formation in mASC(db-/db-)-treated diabetic mice as compared with the respective control groups. Furthermore, locally applied mASCs(db-/db-) significantly enhanced neovascularization and osteogenic differentiation. Moreover, bone remodeling was upregulated in stem cell treatment groups. Local application of mACSs can restore impaired diabetic bone regeneration and may represent a therapeutic option for the future.
引用
收藏
页码:836 / 844
页数:9
相关论文
共 43 条
  • [41] Global prevalence of diabetes - Estimates for the year 2000 and projections for 2030
    Wild, S
    Roglic, G
    Green, A
    Sicree, R
    King, H
    [J]. DIABETES CARE, 2004, 27 (05) : 1047 - 1053
  • [42] Repeated Systemic Administration of Human Adipose-Derived Stem Cells Attenuates Overt Diabetic Nephropathy in Rats
    Zhang, Li
    Li, Kanghua
    Liu, Xiangfei
    Li, Diangeng
    Luo, Congjuan
    Fu, Bo
    Cui, Shaoyuan
    Zhu, Fei
    Zhao, Robert Chunhua
    Chen, Xiangmei
    [J]. STEM CELLS AND DEVELOPMENT, 2013, 22 (23) : 3074 - 3086
  • [43] Zuk P., 2013, ISRN STEM CELLS, V2013, P1, DOI [DOI 10.1155/2013/713959, 10.1155/2013/713959]